Everett Harris & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Everett Harris & Co's DGX Position: Q1 2022 in Review
Everett Harris & Co sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 1,220 shares — an estimated $211K sold.
Everett Harris & Co first reported a position in DGX in Q1 2017 and held it in 20 quarters. The position peaked at $846K in Q2 2020. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- Everett Harris & Co reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
- Everett Harris & Co sold 1,220 Quest Diagnostics shares in Q1 2022, an estimated $211K.
- Everett Harris & Co first reported a position in Quest Diagnostics in Q1 2017 and held it in 20 quarters.
- Everett Harris & Co's Quest Diagnostics position peaked at $846K in Q2 2020.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on Everett Harris & Co's 13F filing for Q1 2022, filed 22 Apr 2022.